Prostate Cancer Recurrent
47
12
16
17
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.3%
2 terminated out of 47 trials
89.5%
+3.0% vs benchmark
19%
9 trials in Phase 3/4
35%
6 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (47)
Lab Research Using Mini-tumors to Study Prostate Cancer Treatments
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
PET-MR-PSA Prostate Cancer Recidive Study
Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy
Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer
Using Meditation for Oncology Anxiety